Bringing the near future to light.
Our portfolio companies are harnessing the power of computation to reprogram, engineer, scale, digitize, miniaturize, visualize, and grow the future.
- A-ALPHA BIOAccelerating therapeutic discovery by measuring millions of protein-protein interactions at a time
- APPIA BIOScaling manufacturing to unlock the promise of off-the-shelf cell therapies
- CANAERYBuilding a nose-computer interface to decode the hidden world of scent
- CELLCHORUSHigh throughput single-cell analysis for development of cell therapies
- CHECKERSPOTSynthetic biology and chemistry to produce novel bio-derived oils from microalgae
- COPERNIC CATALYSTSUsing physics-based computational modeling to design catalysts for sustainable drop-in chemicals and efuels
- CYTOVALEClinical diagnostics to measure biophysical markers of single cells
- ECOVATIVE DESIGNMycelium technology driving plant-based meats, biodegradable packaging and textiles
- EPANA BIOAdvancing autoimmune care with precision therapies powered by genomics and AI.
- ENPLUSONE BIOHarnessing the power and flexibility of enzymes to deliver RNA to the world
- IMMUSOFTGenetically modifying B cells to create sustained, protein-producing therapeutics in the body
- INCENDIA THERAPEUTICSNovel therapeutic platform reprogramming the tumor microenvironment for recalcitrant tumors
- MODERN MEADOWBuilding enhanced functionality through biofabrication
- NOETIKLeveraging advanced machine learning methods to discover and develop cancer immunotherapies
- PARALLEL BIOPutting the immune system in a dish to improve drug discovery
- PASSKEY THERAPEUTICSDiscovering multifunctional drugs for common-yet-complex diseases through advanced computation
- PHANTOM NEUROBuilding a system to help people control robotic limbs using low-risk implantable sensors, AI, and enabling software
- SHIRATRONICSNovel neuromodulation technologies to combat debilitating migraine headaches
- STRM.BIOLeveraging extracellular vesicles to deliver gene therapies in-vivo
- SURF BIOA stabilization platform that addresses some of drug delivery’s most difficult challenges
- TFC THERAPEUTICSTargeting foundational cancer cells to develop better therapies
- TWELVETransforming industrial carbon dioxide emissions into useful chemicals
- VITRA LABSReimagining fertility with next generation IVF
- ZYMOCHEMDeveloping microbes and bioprocesses for the sustainable and profitable production of chemicals from renewable resources
PREVIOUSLY
Breakout Labs
This isn’t our first rodeo. As founders of Breakout Labs at the Thiel Foundation, we have a long history of investing in and coalescing the ecosystem for early-stage, deep science companies.
